Cellares rebukes Bristol Myers’ criticism of its cell therapy technology

Cell ther­a­py man­u­fac­tur­ing start­up Cel­lares is de­fend­ing it­self against Bris­tol My­ers Squibb af­ter the drug­mak­er pulled out of a con­tract claim­ing Cel­lares’ com­mer­cial man­u­fac­tur­ing tech­nol­o­gy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.